Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

Lawsuits have been piling up against Merck & Co. with regard to the defendants’ medication, Propecia (finasteride). The lawsuits typically claim that the drug is unreasonably dangerous and defective, and that it has caused severe side effects. Now, a Florida resident has filed a new Propecia lawsuit claiming breast cancer... Read more »

Low T drug lawsuits alleging life-altering complications from Androgel, Testim and other testosterone supplements continue to mount in courtrooms across the nation. Plaintiffs claim they were inadequately warned about the risk of cardiovascular injury, stroke, heart attack and other severe health complications by the manufacturers of testosterone replacement products. A... Read more »

Pharmaceutical giant Bayer has already resolved more than 17,000 Yaz and Yasmin lawsuits involving venous clot injuries, pulmonary embolism and deep vein thrombosis, but hundreds more are still pending in multidistrict litigation No. 2100. While the MDL is still marshalling discovery common to all cases, the presiding Judge, Honorable David... Read more »

The judge in one of the early Actos bladder cancer trials has upheld a record-breaking $9 billion punitive damages award against Takeda Pharmaceuticals and Eli Lilly, who recently attempted to have the Actos lawsuit award thrown out. U.S. District Judge Rebecca Doherty ruled that the jurors who assigned the award... Read more »

According to the findings of a new study, published by the Journal of Clinical Psychopharmacology, the powerful antipsychotic drug Risperdal shows a positive correlation to the development of abnormal breast tissue in men – a condition known as gynecomastia. The study specifically concluded that the risk of gynecomastia extends not... Read more »

On August 15, the Alabama Supreme Court ruled that brand name prescription drug makers can be held liable for claims brought by plaintiffs seeking damages for adverse side effects from generic drugs manufactured by different companies. In an overwhelming 6-3 decision, the court ruled that the manufacturers of Reglan ─... Read more »

A Tennessee family filed a Xarelto fatal bleed lawsuit in the U.S. District Court for the Eastern District of New York on August 14, 2014. The case is one of many against drug manufacturer Janssen, a subsidiary of Johnson & Johnson. In the first quarter of 2013, the 680 formal... Read more »

According to the details of a quarterly report filed by drug giant AstraZeneca, it has agreed to settle 84 cases with plaintiffs having filed Byetta lawsuits alleging serious injury. The drug maker did not immediately reveal the amount of each settlement, and its report also reveals at least 409 other... Read more »

Judge Cynthia Rufe, who is overseeing MDL No. 2342 in the U.S. District Court for the Eastern District of Pennsylvania, recently remanded a Zoloft lawsuit back to Missouri state court, reports Harris Martin. The MDL judge found that the 25 claimant families did not fraudulently misjoin their complaints into a... Read more »